Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating efficacy, safety, and pharmacokinetics of etokimab (ANB020) in adults with moderate-to-severe atopic dermatitis com…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial of bermekimab for adult atopic dermatitis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial update describing pharmacodynamic blood characteristics of ICP-332 in patients with moderate to severe atopic dermatitis.
-
FDA label_change · 2023-05-10FDA Approved: METHYLPREDNISOLONE ACETATE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for methylprednisolone acetate by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants [Phase 3]
Phase 3 trial update for the PEBBLES study evaluating a preventive strategy for eczema and food allergy in high-risk infants.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Alitretinoin in the Treatment of Chronic Hand Eczema [Phase 3]
Phase 3 clinical trial of alitretinoin for chronic hand eczema has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase II study in adults with moderate to severe atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects [Phase 3]
A Phase 3 trial evaluating IDP-124 Lotion for moderate-to-severe atopic dermatitis in adults and children has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301) [Phase 3]
Phase 3 trial update on IDP-124 Lotion for moderate to severe atopic dermatitis in adults and children; results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating MSTT1041A for moderate to severe atopic dermatitis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis [Phase 2]
Phase 2 trial update on safety and efficacy of CD5024 0.3% Cream in adults with atopic dermatitis; results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response [Phase 4]
Phase 4 trial exploring optimization of cyclosporin in atopic dermatitis using multiomic predictive models to predict treatment response.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD) [Phase 2]
Phase 2 PK and safety study of nemolizumab in adolescents with atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function [Phase 2]
Phase 2 trial evaluating tralokinumab for atopic dermatitis and its effects on skin barrier function has completed.
-
FDA approval · 2023-04-18FDA Approved: BETAMETHASONE VALERATE — Original Application (Xiromed, LLC.)
FDA approved Xiromed, LLC's Betamethasone Valerate Foam as an original ANDA, establishing a generic version of betamethasone valerate foam f…
-
FDA approval · 2023-04-03FDA Approved: EUCRISA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for EUCRISA (crisaborole) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for jaktinib in moderate to severe atopic dermatitis completed.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo [Phase 2]
Phase 2 trial evaluating a new phototherapy regimen plus oral vitamin D versus placebo for long-term control in atopic dermatitis, completed…
-
CLINICAL_TRIALS withdrawal · 2023-03-21Clinical Trial Update: CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis [Phase 3]
Phase 3 trial of CBP-201 for moderate-to-severe atopic dermatitis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis [Phase 3]
Phase 3 study evaluating long-term maintenance treatment with once-daily Crisaborole 2% ointment in pediatric and adult patients with mild-t…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating safety of upadacitinib in combination with topical corticosteroids for moderate to severe atopic dermatitis in adol…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial of bermekimab in moderate to severe atopic dermatitis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 trial assessing safety and efficacy of lebrikizumab in adolescents with moderate-to-severe atopic dermatitis has completed and resul…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis [Phase 2]
Phase 2 trial update on ARQ-151 Cream showing safety and efficacy in adolescents and adults with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Metal Panel Allergen Patch Test Study [Phase 3]
A Phase 3 clinical trial update for a metal panel allergen patch test study in atopic dermatitis (eczema) is reported with unknown status.